Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

JCO Precis Oncol. 2022 Jan:6:e2100400. doi: 10.1200/PO.21.00400.

Marina Gaule^{1

2}, Camilla Pesoni^{1

2}, Alberto Quinzii^{1

2}, Camilla Zecchetto^{1

2}, Simona Casalino^{1

2}, Valeria Merz^{2

3}, Serena Contarelli², Silvia Pietrobono², Elena Vissio⁴, Luca Molinaro⁴, Enrica Manzin⁵, Roberta Volpatto⁵, Giorgio Vellani⁵, Davide Melisi^{1

2}

¹ Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
² Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy.
³ Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy.
⁴ Pathology Unit, Department of Medical Sciences, University of Turin and Città della Salute e della Scienza Hospital, Turin, Italy.
⁵ Medical Oncology Unit, ASL Torino 4, Turin, Italy.

No abstract available

Publication types